Marketview360 Logo
ScreensWatchlistMarketsNewsAI AssistantPricing
⌘K
Marketview360 Logo

The fastest way to screen, analyze, and track US equities. Real-time data, powerful ratios, and clean design for the modern investor.

Product

  • Stock Screener
  • Market Overview
  • Market News
  • AI Assistance

Support

  • Help Center
  • Feedback
  • About
  • Blog
  • System Status

© 2026 Marketview360 Inc. All rights reserved.

PrivacyTermsCookiesDisclaimer
Home/
Screener/
ABBV.US
AbbVie Inc logo

AbbVie Inc

ABBV.US
NYSE•Healthcare
Low: $159.05High: $241.12
$209.40
52 Week Range
-0.81%
Market Close
Key Metrics
Peer Comparison
TickerNamePriceMkt CapP/E1D %
GILD.USGilead Sciences Inc$184.91B21.97-1.92%
BSX.USBoston Scientific Corp$114.04B39.61-1.43%
EXAS.USEXACT Sciences Corporation$19.73B0.00-0.68%
WST.USWest Pharmaceutical Services Inc$18.32B37.46-1.92%
BPMC.USBlueprint Medicines Corp$8.37B0.000.14%
MOH.USMolina Healthcare Inc$7.93B17.273.24%
MMED.USMiniMed Group, Inc. Common Stock$4.48B0.00-5.24%
AMRX.USAmneal Pharmaceuticals, Inc. Class A Common Stock$4.34B1381.00-1.74%
BCRX.USBioCryst Pharmaceuticals Inc$1.87B0.00-2.41%
NBTX.USNanobiotix$1.50B0.00-4.37%
Latest News

No recent news available for ABBV.US

See news for other symbols →
Company Profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq…

Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
57,000
Founded
2013
Country
Not available
Website
https://www.abbvie.com
Analyst Ratings
Buy
Target: $248.69(+18.8%)
Based on 28 analysts
0
Strong Sell
0
Sell
12
Hold
4
Buy
12
Strong Buy